UCSF's John L.R. Rubenstein, MD, PhD, has been named as the 2026 recipient of the prestigious Gruber Neuroscience Prize .
The 2026 Gruber Neuroscience Prize will be awarded to UC San Francisco neuroscientist and Nina Ireland Distinguished Professor in Child Psychiatry John L.R. Rubenstein, MD, PhD, for his pioneering work on mammalian forebrain development, a structure which is responsible for functions such as cognition, memory and perception. This work has helped shed light on causes of multiple neurological and psychiatric disorders. These discoveries have led him and collaborators to develop a novel therapeutic approach in which cortical interneurons are transplanted into the hippocampus of patients with intractable focal epilepsy. Initial clinical trials have already yielded encouraging results.
Rubenstein has been a faculty member in the UCSF Department of Psychiatry and Behavioral Sciences since 1991, where he directs the Nina Ireland Laboratory of Developmental Neurobiology. He is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences, and has received numerous honors over the course of his career, including the American Psychiatric Association’s Blanch F. Ittleson Award, the Child Mind Institute’s Distinguished Scientist Award, the Brain & Behavior Research Foundation's Ruane Prize for OUtstanding Child and Adolesacent Psychiatric Research, and the W. Maxwell Cowan Award for Developmental Neuroscience.
Rubenstein’s research led to the discovery of the transcription factors that direct the development of excitatory and inhibitory neurons in the developing forebrain. Rubenstein, along with his collaborators, were able to elucidate the spatial and temporal dynamics of forebrain patterning, which included the discovery that inhibitory neurons generated in the basal ganglia, after which a subset migrate to the hippocampus and cortex.
Rubenstein and his collaborators then characterized the molecular pathways responsible for neuronal cell type specification, which included identifying the regulatory sequences, called enhancers, which transcription factors bind to, in order to direct gene expression.
“We are proud to present Rubenstein the 2026 Neuroscience Prize for a number of reasons,” said Joshua Sanes, Jeff C. Tarr Professor of Molecular and Cellular Biology at Harvard and chair of the Selection Advisory Board to the Prize. “Rubenstein’s work has led to an understanding of how the mammalian forebrain develops, which includes elucidating the transcription factors and regulatory sequences that are involved in forebrain patterning. This work has also led to a greater understanding of developmental conditions such as epilepsy and autism spectrum disorder.”
The Gruber Neuroscience Prize, which includes a $500,000 award, will be presented to Rubenstein on November 15 at the Annual Meeting of the Society for Neuroscience in Washington DC.
In addition to the cash award, the Rubenstein will receive a gold laureate pin and a citation that reads:
The Gruber Foundation proudly presents the 2026 Neuroscience Prize to John L. R. Rubenstein for his groundbreaking research on the development of the mammalian forebrain, which is responsible for myriad functions, including cognition, memory, and perception.
Rubenstein began by identifying transcription factors that act as master developmental regulators of cortex and other forebrain areas. He then used elegant genetic approaches to probe mechanisms by which these factors regulate formation and disparate origins of excitatory and inhibitory neurons, and their patterning into discrete areas, layers and nuclei. He went on to characterize molecular programs underlying neuronal type specification by identifying the regulatory sequences, called enhancers, that bind transcription factors to control gene expression.
A physician-scientist, Rubenstein has used his discoveries as an entry point for analyzing brain disorders such as autism and epilepsy. Recently, he worked with colleagues to devise a revolutionary therapeutic approach to refractory epilepsy, based on the transplantation of cortical interneuron stem cells.
About the Gruber Prizes
The Gruber International Prize Program honors individuals in the fields of cosmology, genetics, and neuroscience, whose groundbreaking work provides new models that inspire and enable fundamental shifts in knowledge and culture. The Selection Advisory Boards choose individuals whose contributions in their respective fields advance our knowledge and potentially have a profound impact on our lives.
The Gruber Foundation was established in 1993 by the late Peter Gruber and his wife Patricia Gruber, and began its International Prize Program in 2000. The Neuroscience Prize honors scientists for major discoveries that have advanced the understanding of the nervous system.
About UCSF Psychiatry and Behavioral Sciences
The UCSF Department of Psychiatry and Behavioral Sciences and the Langley Porter Psychiatric Institute are among the nation's foremost resources in the fields of child, adolescent, adult, and geriatric mental health. Together they constitute one of the largest departments in the UCSF School of Medicine and the UCSF Weill Institute for Neurosciences, with a focus on providing unparalleled patient care, conducting impactful research, training the next generation of behavioral health leaders, and advancing diversity, health equity, and community across the field.
UCSF Psychiatry and Behavioral Sciences conducts its clinical, educational, and research efforts at a variety of locations in Northern California, including the UCSF Nancy Friend Pritzker Psychiatry Building; UCSF Langley Porter Psychiatric Hospital; UCSF Health medical centers and community hospitals across San Francisco; UCSF Benioff Children’s Hospitals in San Francisco and Oakland; Zuckerberg San Francisco General Hospital and Trauma Center; the San Francisco VA Health Care System; UCSF Fresno; and numerous community-based sites around the San Francisco Bay Area.
About the UCSF Weill Institute for Neurosciences
The UCSF Weill Institute for Neurosciences, established by the extraordinary generosity of Joan and Sanford I. "Sandy" Weill, brings together world-class researchers with top-ranked physicians to solve some of the most complex challenges in the human brain.
The UCSF Weill Institute leverages UCSF’s unrivaled bench-to-bedside excellence in the neurosciences. It unites three UCSF departments—Psychiatry and Behavioral Sciences, Neurology, and Neurological Surgery—that are highly esteemed for both patient care and research, as well as the Neuroscience Graduate Program, a cross-disciplinary alliance of nearly 100 UCSF faculty members from 15 basic-science departments, as well as the UCSF Institute for Neurodegenerative Diseases, a multidisciplinary research center focused on finding effective treatments for Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, and other neurodegenerative disorders.
About UCSF
The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area.
